SCHEMBL2202876

SCHEMBL2202876

COC(=O)Nc1ccc(C[C@H](NC(=O)c2ccc3c(C4CCCCC4)c4n(c3c2)CCOc2cc(OC)ccc2-4)C(=O)OC)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.42
NR1I2 O75469 5/20 0.40
CYP3A4 P08684 4/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40
SCN5A Q14524 2/20 0.39
SCN9A Q15858 1/20 0.37
MAPT P10636 1/20 0.37
PRKCA P17252 1/20 0.36
MMP12 P39900 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771941 0.95 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL771846 0.95 KCNH2 (0.41) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL12510477 0.94 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL772942 0.93 NR1I2 (0.41) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL774124 0.93 KCNH2 (0.41) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL772487 0.92 LNPEP (0.43) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL771931 0.92 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL771379 0.91 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL771658 0.91 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL773343 0.91 KCNH2 (0.42) KCNH2NR1I2CYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977331-B1 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor JAPAN TOBACCO INC. (JP) 2011-07-12 US disclosed
US-7977331-B1 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor JAPAN TOBACCO INC. (JP) 2011-07-12 US disclosed
US-7977331-B1 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor JAPAN TOBACCO INC. (JP) 2011-07-12 US disclosed